Incorporated in 2008, Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients’ specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.
The generic products supplied by the company have a wide application in paint, food, pharma, and adhesive industry. The company is involved in a contract manufacturing facility, supply and outsource of medicines and pharma formulation to hospitals, NGO, government and healthcare institutes. SPIL has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable.
The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulation & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customised solutions.
The competitive strengths of the company are:
1. Customer-centric and order-driven business model
2. Wide range of product offerings
3. Contract manufacturing facility arrangements
4. Strong distribution, marketing, and sales network
5. Diversified business operations
Sudarshan Pharma Industries SME IPO Subscription Status Live
Last Data Updated on 14th March 2023, 07:00 PM (Refresh Page)
| Category | Day 1 | Day 2 | Day 3 | Day 4 |
| QIB | 0.00 | 0.00 | 0.00 | 1.01 |
| NII | 0.37 | 0.38 | 0.58 | 0.81 |
| Retail | 0.47 | 0.67 | 0.88 | 1.20 |
| Total | 0.40 | 0.52 | 0.71 | 1.06 |
Sudarshan Pharma Industries SME IPO Dates & Price Band :
| IPO Open: | Mar 9, 2023 |
| IPO Close: | Mar 14, 2023 |
| IPO Size: | Approx ₹50.10 Crores |
| Price Band: | ₹71 to ₹73 per share |
| Listing on: | NSE SME |
| Retail Portion: | Not less than 35% of the Net Issue |
| Equity: | 6,862,400 Equity Shares |
| Face Value: | ₹10 Per Equity Share |
Sudarshan Pharma Industries SME IPO Market Lot:
- Shares: 6,862,400 Shares
- Minimum Amount: ₹116,800
- Maximum Amount: ₹116,800
Sudarshan Pharma Industries SME IPO Allotment & Listing:
- Basis of Allotment: Mar 17, 2023
- Refunds: Mar 20, 2023
- Credit to Demat accounts: Mar 21, 2023
- Listing: Mar 22, 2023
Sudarshan Pharma Industries SME IPO Grey Market Premium
Sudarshan Pharma Industries SME IPO Allotment Status
Sudarshan Pharma Industries SME IPO Listing Date